184 related articles for article (PubMed ID: 22758896)
1. Industry sponsorship of scientific meetings: peaks and troughs.
Isaacs D
J Paediatr Child Health; 2012 Jul; 48(7):547. PubMed ID: 22758896
[No Abstract] [Full Text] [Related]
2. Sponsored medical education?
Nagral S
Issues Med Ethics; 1998 Jan; 6(1):3. PubMed ID: 16267919
[No Abstract] [Full Text] [Related]
3. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
Rutledge P; Crookes D; McKinstry B; Maxwell SR
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):663-7. PubMed ID: 14762982
[TBL] [Abstract][Full Text] [Related]
4. "Evidence-debased medicine" and the integrity of the medical profession.
Elliott RL
J Clin Ethics; 2011; 22(1):71-3. PubMed ID: 21595357
[TBL] [Abstract][Full Text] [Related]
5. Involvement of pharmaceutical companies at scientific meetings.
Brink A
Cardiovasc J Afr; 2010; 21(3):131. PubMed ID: 20532449
[No Abstract] [Full Text] [Related]
6. Physicians, Industry Payments for Food and Beverages, and Drug Prescribing.
Steinbrook R
JAMA; 2017 May; 317(17):1753-1754. PubMed ID: 28464155
[No Abstract] [Full Text] [Related]
7. [Is it pertinent to investigate the relations between physicians and the drug industry].
Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
[TBL] [Abstract][Full Text] [Related]
8. Physician education and the pharmaceutical industry.
Johnson RG
Chest; 2001 Apr; 119(4):995-6. PubMed ID: 11296157
[No Abstract] [Full Text] [Related]
9. Considerations in the relationship between the American College of Chest Physicians and industry.
Lever A
Chest; 2001 Apr; 119(4):1257-9. PubMed ID: 11296196
[No Abstract] [Full Text] [Related]
10. Time for introspection.
Varkey B
Chest; 2001 Apr; 119(4):1255-6. PubMed ID: 11296195
[No Abstract] [Full Text] [Related]
11. US Senate committee investigates conflicts of interest in industry funded medical education.
Tanne JH
BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162
[No Abstract] [Full Text] [Related]
12. [Is accepting an invitation to a conference on Hawaii unethical?].
Andrén-Sandberg A
Lakartidningen; 2005 Apr 4-10; 102(14):1057-8, 1060. PubMed ID: 15892476
[No Abstract] [Full Text] [Related]
13. The ethics behind medical conferences: a view from India.
Sharma V; Sharma A
J Med Ethics; 2010 Jul; 36(7):445-6. PubMed ID: 20558437
[TBL] [Abstract][Full Text] [Related]
14. [The "to be or not to be" of the scientific congresses. Reduced resources and virtual meetings hit against pleasure-trips].
Rössner S
Lakartidningen; 2003 Mar; 100(11):952-5. PubMed ID: 15148723
[No Abstract] [Full Text] [Related]
15. Must "no see" always mean a "no know"?
Gamble GL
PM R; 2009 Jan; 1(1):87-8. PubMed ID: 19627879
[No Abstract] [Full Text] [Related]
16. Medical ethics, research and the pharmaceutical industry.
Abud-Mendoza C
Reumatol Clin; 2012; 8(5):233-5. PubMed ID: 22608694
[No Abstract] [Full Text] [Related]
17. Future directions in industry funding of continuing medical education.
Steinbrook R
Arch Intern Med; 2011 Feb; 171(3):257-8. PubMed ID: 21325116
[No Abstract] [Full Text] [Related]
18. Dealing with drug dependency: a commentary on ILAE's partnership with the pharmaceutical industry.
Avanzini G; Engel J
Epilepsia; 2007 Oct; 48(10):1821-4. PubMed ID: 17683507
[No Abstract] [Full Text] [Related]
19. Ethical concerns of congresses and joint winter meetings of the Spanish Society of Pneumology and Thoracic Surgery.
Chiner E; Fernández-Fabrellas E; de Lucas P
Arch Bronconeumol; 2013 May; 49(5):201-6. PubMed ID: 23298823
[TBL] [Abstract][Full Text] [Related]
20. Expenses for meetings and fees for service: details of 'disclosure' required of pharmaceutical companies.
Shurlock B
Eur Heart J; 2013 Dec; 34(47):3589-90. PubMed ID: 24335158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
